Japan researchers close in on stem cell trial

February 14, 2013 by Kyoko Hasegawa
A scientist is pictured on August 27, 2010 working on stem cells at a US university. Researchers in Japan have moved one step closer to clinical trials using adult stem cells in a therapy they hope will prove a cure for common sight problems, an official said Thursday.

Researchers in Japan have moved one step closer to clinical trials using adult stem cells in a therapy they hope will prove a cure for common sight problems, an official said Thursday.

The ethics committee at the Institute for Biomedical Research and Innovation in Kobe, west Japan, on Wednesday approved a trial treatment for age-related (AMD) using induced Pluripotent Stem (iPS) cells.

The trial is aimed at creating that can be transplanted into the eyes of patients suffering from AMD, a presently incurable disease that affects mostly middle-aged and older people and can lead to blindness.

The institute, together with the government-backed research institute Riken, "will submit an application for a clinical trial with Riken to the Health Ministry by the end of next month," hospital official Kosuke Nagi told AFP.

If a clinical trial using iPS cells is approved, it "would be the first ever", a health ministry official said, adding a trial using —harvested from —had been undertaken by a US firm.

The ministry's deliberation process will take a few months before approval, the official said.

Stem cells—infant cells that develop into the specialised tissues of the body—have sparked great excitement because they offer the chance of rebuilding organs damaged by disease or accident.

Until fairly recently, the only way to obtain stem cells was to harvest them from embryos.

Religious conservatives, amongst others, have objected to research on human embryonic stem cells because they hold that the destruction of a , necessary for the harvest, is wrong.

But pioneering work done in 2006 by Shinya Yamanaka at Kyoto University, a Nobel Laureate in medicine last year, succeeded in generating stem cells from .

Like embryonic stemcells, iPS cells are also capable of developing into any cell in the body, but crucially their source material is readily available.

Yamanaka has called for the government to support his research financially, running in a charity marathon to raise funds in 2011, but his Nobel Prize has significantly boosted his clout and the issue enjoys widespread public support in Japan.

Prime Minister Shinzo Abe said last month his government will earmark 110 billion yen ($1.18 billion) for research towards the clinincal use of iPS cells.

Explore further: The future of stem cell research

Related Stories

The future of stem cell research

December 8, 2010

Perhaps no single scientist has had a greater impact on stem cell research than Dr. Shinya Yamanaka. While most of his colleagues were looking for ways to grow human embryonic stem cells into replacement tissues for treating ...

Recommended for you

How bees naturally vaccinate their babies

July 31, 2015

When it comes to vaccinating their babies, bees don't have a choice—they naturally immunize their offspring against specific diseases found in their environments. And now for the first time, scientists have discovered how ...

New insights into the production of antibiotics by bacteria

July 31, 2015

Bacteria use antibiotics as a weapon and even produce more antibiotics if there are competing strains nearby. This is a fundamental insight that can help find new antibiotics. Leiden scientists Daniel Rozen and Gilles van ...

Out of the lamplight

July 31, 2015

The human body is governed by complex biochemical circuits. Chemical inputs spur chain reactions that generate new outputs. Understanding how these circuits work—how their components interact to enable life—is critical ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.